Melissa Starovasnik
Director/Board Member bei TWIST BIOSCIENCE CORPORATION
Vermögen: 588 588 $ am 31.03.2024
Profil
Melissa A.
Starovasnik is an Independent Director at Twist Bioscience Corp.
She previously worked as Vice President-Protein Sciences at Genentech, Inc. from 2011 to 2017.
She received her undergraduate degree in 1987 and her doctorate in 1992 from the University of Washington.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TWIST BIOSCIENCE CORP.
0,03% | 06.02.2024 | 17 155 ( 0,03% ) | 588 588 $ | 31.03.2024 |
Aktive Positionen von Melissa Starovasnik
| Unternehmen | Position | Beginn |
|---|---|---|
| TWIST BIOSCIENCE CORPORATION | Director/Board Member | 06.08.2021 |
Ehemalige bekannte Positionen von Melissa Starovasnik
| Unternehmen | Position | Ende |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.01.2017 |
Ausbildung von Melissa Starovasnik
| University of Washington | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TWIST BIOSCIENCE CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
